← Leaderboards
Nneoma Adaku
Weill Medical Coll Of Cornell Univ
$187,905
Attributed
$187,905
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $52.7K · FY2021–24$100K$75K$50K$25K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$187,905 · 1
By mechanism
F30$187,905 · 1
Top collaborators
No co-investigators on record.
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Jorge Moscat$21,067,408
- Costantino Iadecola$45,312,269
- David Artis$33,334,671
- Gregory F Sonnenberg$27,142,830
- Augustine M Choi$36,719,348
Others in their field
Other Emerging Leaders on “Apolipoprotein E”
- Susan Abushakra · Alzheon, Inc.$47,690,244
- Susan M Landau · University Of California Berkeley$47,252,026
- Maria C Carrillo · Indiana University Indianapolis$19,489,876
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$11,320,710
- Heidi Irma Jacobs · Massachusetts General Hospital$9,651,108
- Claudia L Satizabal · Boston University Medical Campus$9,286,743
Research focus
Apolipoprotein EGlycoproteinsBindingCancer BiologyCancer PatientAnimal ModelCellsCell SurfaceCell TypeCessation Of LifeCollaborative EnvironmentConflict (Psychology)Crispr/Cas TechnologyCell LineDoctor Of PhilosophyFunctional DisorderFutureGene ExpressionGene TargetingGeneticGenetically Engineered MouseGenetic TranscriptionGenetic VariantImmunotherapy
Grant awards (4)
Elucidating the Function of LRP1 in APOE-mediated Suppression of Melanoma Metastasis$32,423
F30 · FY2024 · CA · contact PI
Elucidating the Function of LRP1 in APOE-mediated Suppression of Melanoma Metastasis$52,694
F30 · FY2023 · CA · contact PI
Elucidating the Function of LRP1 in APOE-mediated Suppression of Melanoma Metastasis$51,752
F30 · FY2022 · CA · contact PI
Elucidating the Function of LRP1 in APOE-mediated Suppression of Melanoma Metastasis$51,036
F30 · FY2021 · CA · contact PI